FDA Approves New H1N1 Vaccine

The Federal Food and Drug Administration has approved a supplemental biologics license application for a new H1N1 vaccine made by GlaxoSmithKline.

The approval allows the company to manufacture flu vaccines for adults which target this year's H1N1 strain. The Department of Health and Human Services has already placed an order with the drugmaker for 7.6 million doses.

GlaxoSmithKline expects to begin shipping the vaccine in December.


You must be logged in to post comments.

Username:
Password (case sensitive):
Remember Me:

Read Comments

Comments are posted from viewers like you and do not always reflect the views of this station.
  • by Audra Location: SoCal on Nov 11, 2009 at 08:07 AM
    If they're so sure the vaccine is so safe... why is Glaxo only being approved to manufacture it for adults? mmmhhhmm
WITN

275 E. Arlington Blvd. Greenville, NC 27858 252-439-7777
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 69739987 - witn.com/a?a=69739987
Gray Television, Inc.